Treating relapsed or refractory Philadelphia chromosome-negative acute lymphoblastic leukemia: liposome-encapsulated vincristine
Tyler Davis, Sherif S Farag Department of Internal Medicine, Division of Hematology and Oncology, Indiana University School of Medicine, Indianapolis, IN, USA Abstract: Acute lymphoblastic leukemia (ALL) remains a disease with poor outcomes in adults. While induction chemotherapy achieves a complete...
Main Authors: | Davis T, Farag SS |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-09-01
|
Series: | International Journal of Nanomedicine |
Online Access: | http://www.dovepress.com/treating-relapsed-or-refractory-philadelphia-chromosome-negative-acute-a14365 |
Similar Items
-
Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia
by: Enrico Maffini, et al.
Published: (2019-05-01) -
Vincristine sulfate liposomal injection for acute lymphoblastic leukemia
by: Soosay Raj TA, et al.
Published: (2013-11-01) -
Inotuzumab ozogamicin and blinatumomab sequential therapy for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia
by: Tomoaki Ueda, et al.
Published: (2022-01-01) -
Vincristine sulfate liposomal injection for acute lymphoblastic leukemia [Corrigendum]
by: Soosay Raj TA, et al.
Published: (2013-12-01) -
Venetoclax durable response in adult relapsed/refractory Philadelphia-negative acute lymphoblastic leukemia with JAK/STAT pathway alterations
by: Anna Ferrari, et al.
Published: (2023-05-01)